Literature DB >> 19171876

Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB.

Thorsten Hagemann1, Subhra K Biswas, Toby Lawrence, Antonio Sica, Claire E Lewis.   

Abstract

The pivotal role of tumor-associated macrophages (TAMs) in tumor progression is now well established. TAMs have been shown to influence multiple steps in tumor development including the growth, survival, invasion, and metastasis of tumor cells as well as angiogenesis and lymphangiogenesis in tumors. The molecular circuits that polarize TAMs toward such a protumoral phenotype are now the focus of intense investigation. The transcription factor, nuclear factor-kappaB (NF-kappaB), is a master regulator of many cellular processes and been shown to regulate various pathways that impact on the function of TAMs. Much evidence for this has come from the use of elegant transgenic murine tumor models in which modification of single components of the NF-kappaB signaling pathway has been shown to regulate the pro-tumor repertoire of TAMs. Here, we outline this evidence and attempt to reconcile the various views that have emerged recently over the exact role of NF-kappaB in this phenomenon.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19171876      PMCID: PMC2869029          DOI: 10.1182/blood-2008-12-172825

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  92 in total

Review 1.  IRF family of transcription factors as regulators of host defense.

Authors:  T Taniguchi; K Ogasawara; A Takaoka; N Tanaka
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  Critical role of C/EBPdelta and C/EBPbeta factors in the stimulation of the cyclooxygenase-2 gene transcription by interleukin-1beta in articular chondrocytes.

Authors:  B Thomas; F Berenbaum; L Humbert; H Bian; G Béréziat; L Crofford; J L Olivier
Journal:  Eur J Biochem       Date:  2000-12

3.  Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages.

Authors:  A Sica; A Saccani; B Bottazzi; N Polentarutti; A Vecchi; J van Damme; A Mantovani
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

4.  Requirement for STAT1 in LPS-induced gene expression in macrophages.

Authors:  Y Ohmori; T A Hamilton
Journal:  J Leukoc Biol       Date:  2001-04       Impact factor: 4.962

Review 5.  Inflammation and cancer: back to Virchow?

Authors:  F Balkwill; A Mantovani
Journal:  Lancet       Date:  2001-02-17       Impact factor: 79.321

Review 6.  IL-4/IL-13 signaling beyond JAK/STAT.

Authors:  H Jiang; M B Harris; P Rothman
Journal:  J Allergy Clin Immunol       Date:  2000-06       Impact factor: 10.793

7.  Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages.

Authors:  D J Wadleigh; S T Reddy; E Kopp; S Ghosh; H R Herschman
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

8.  Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis.

Authors:  Li Yang; Laura M DeBusk; Koari Fukuda; Barbara Fingleton; Brenda Green-Jarvis; Yu Shyr; Lynn M Matrisian; David P Carbone; P Charles Lin
Journal:  Cancer Cell       Date:  2004-10       Impact factor: 31.743

Review 9.  Exploring the full spectrum of macrophage activation.

Authors:  David M Mosser; Justin P Edwards
Journal:  Nat Rev Immunol       Date:  2008-12       Impact factor: 53.106

10.  Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy.

Authors:  E Y Lin; A V Nguyen; R G Russell; J W Pollard
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

View more
  90 in total

Review 1.  Macrophage-tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands.

Authors:  Thomas Schmidt; Isabel Ben-Batalla; Alexander Schultze; Sonja Loges
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

Review 2.  Important aspects of Toll-like receptors, ligands and their signaling pathways.

Authors:  Z L Chang
Journal:  Inflamm Res       Date:  2010-07-01       Impact factor: 4.575

Review 3.  Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia.

Authors:  John G Gribben; Chitra Hosing; David G Maloney
Journal:  Biol Blood Marrow Transplant       Date:  2011-01       Impact factor: 5.742

4.  Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer.

Authors:  Neveen Said; Steven Smith; Marta Sanchez-Carbayo; Dan Theodorescu
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

Review 5.  Chemokines, chemokine receptors and the gastrointestinal system.

Authors:  Hiroshi Miyazaki; Kazuaki Takabe; W Andrew Yeudall
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.742

6.  New cyclic sulfides, garlicnins I2, M, N, and O, from Allium sativum.

Authors:  Toshihiro Nohara; Masateru Ono; Naho Nishioka; Fuka Masuda; Yukio Fujiwara; Tsuyoshi Ikeda; Daisuke Nakano; Junei Kinjo
Journal:  J Nat Med       Date:  2017-10-30       Impact factor: 2.343

7.  KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation.

Authors:  Faraz Bishehsari; Lijuan Zhang; Usman Barlass; Nailliw Z Preite; Sanja Turturro; Matthew S Najor; Brandon B Shetuni; Janet P Zayas; Mahboobeh Mahdavinia; Abde M Abukhdeir; Ali Keshavarzian
Journal:  Int J Cancer       Date:  2018-08-09       Impact factor: 7.396

8.  The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer.

Authors:  Qiang Zhou; Rui-Qing Peng; Xiao-Jun Wu; Qing Xia; Jing-Hui Hou; Ya Ding; Qi-Ming Zhou; Xing Zhang; Zhi-Zhong Pang; De-Sen Wan; Yi-Xin Zeng; Xiao-Shi Zhang
Journal:  J Transl Med       Date:  2010-02-08       Impact factor: 5.531

Review 9.  Redox regulation in cancer: a double-edged sword with therapeutic potential.

Authors:  Asha Acharya; Ila Das; Des Chandhok; Tapas Saha
Journal:  Oxid Med Cell Longev       Date:  2010 Jan-Feb       Impact factor: 6.543

10.  Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma.

Authors:  Iris Helfrich; Inka Scheffrahn; Sönke Bartling; Joachim Weis; Verena von Felbert; Mark Middleton; Masahi Kato; Süleyman Ergün; Helmut G Augustin; Dirk Schadendorf
Journal:  J Exp Med       Date:  2010-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.